pharm14520240209161306384EMO_en_20240209161306506.png

過去のプログラムはこちら

罫線.png

罫線1

創薬サイエンス_バナーRGB_w250px.gif

創薬サイエンス

7_10051-2：東京大学.jpg

創薬等先端技術支援基盤プラットフォーム

罫線2

第9回精神薬学会バナー500×200.jpg

第9回日本精神薬学会総会・学術集会

第35回日本医療薬学会年会バナー.jpg

第35回日本医療薬学会年会

罫線3

General information

Overview

Announcements(26)

Timetable

Thu. Mar 27, 2025

Fri. Mar 28, 2025

Sat. Mar 29, 2025

Program & Abstract

Sessions

Search presentations

Selected programs of presentations in English

Download Abstracts PDF

Registration

Registration (Non-presenters under 4th year underg

For Participants and Presenters

Participation Certificate PDF

For Participants

For Presenters

How to use "Confit mobile meeting app"

Exhibition

Companies（Equipment exhibits）

Companies（Medical supplies）

Bibliographic information retrieval system

Companies（Books）

Abstract Submission (Oral/Poster Presentation)

Abstract Submission

header_en_20240313161625152.png

app_icon.png

Profile management

Bookmark

Announcements

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Outcomes of clinical pharmacy services in oncology

The Federation of Pharmaceutical Societies of Japan, established in July 2023, functions as a platform for research exchange and sharing knowledge between basic and clinical researchers, playing a crucial role in consolidating pharmaceutical expertise. It is anticipated to contribute significantly to the advancement of cancer treatment and the improvement of patients' quality of life. Many cancer patients grapple with various side effects, as well as psychological and economic challenges associated with pharmacotherapy. Clinical pharmacists thus play a crucial role in cancer care, acting as central figures in identifying and resolving issues that impact patients' lives, using their pharmaceutical expertise. In the clinical setting, pharmacists collect and analyze information, collaborating with other healthcare professionals to provide optimal drug therapy and contribute to patient satisfaction and enhanced quality of life. On the other hand, challenges arise in healthcare due to a lack of evidence, necessitating clinical pharmacists to actively contribute to the creation of new evidence. This symposium, jointly organized by the Pharmaceutical Society of Japan and the Japanese Society of Pharmaceutical Health Care and Sciences for the second time. It brings together experts such as Board certified Oncology Pharmacists and Board certified Senior Oncology Pharmacists to discuss clinical research and the generation of new evidence. The symposium is anticipated to serve as a catalyst for discussions across a broad spectrum of fields, including outcomes of clinical pharmacy services in oncology, development of prevention methods for anticancer drug-induced side effect using data science, development of personalized precision dosing for molecularly targeted cancer therapies, prospects and challenges for future clinical pharmacy research. We look forward to the symposium becoming a milestone event that paves the way for "Pioneering New Cancer Therapies".

Pioneering Cancer Medicine with Pharmacy Expertise (the 2nd time) —Aiming to create evidence—

The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Presentation Information

[JS10-1]Outcomes of clinical pharmacy services in oncology

Password required to view